Physician profile
Ali Emami
NPI 1992767966
$13,746.55
in general payments reported to CMS, 2019-2025
58 companies · $2,632 in 2025
The $2,632 reported for 2025 was more than what 91% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,850 · 2020: $1,579 · 2021: $1,571 · 2022: $1,586 · 2023: $2,188 · 2024: $2,340 · 2025: $2,632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,989 · Education: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,988.95 |
| Education | $171.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,772.25 | 2019-2025 | Repatha, Evenity, Prolia |
| Novo Nordisk INC | $1,472.30 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $1,337.99 | 2019-2025 | Farxiga, Lokelma |
| Bayer Healthcare Pharmaceuticals INC. | $980.21 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $928.07 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $851.71 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Esperion Therapeutics, INC. | $549.49 | 2020-2025 | Nexletol |
| Vifor Pharma, INC. | $474.86 | 2019-2025 | Veltassa |
| Abbvie INC. | $434.47 | 2020-2025 | |
| Xeris Pharmaceuticals, INC. | $356.35 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Tolmar, INC. | $355.77 | 2023-2025 | Jatenzo |
| Merck Sharp & Dohme LLC | $333.04 | 2019-2021 | |
| Glaxosmithkline, LLC. | $241.92 | 2022-2025 | Benlysta, Shingrix, Jesduvroq |
| Medtronic, INC. | $220.79 | 2021-2025 | Minimed 780g, Intellis Adaptivestim |
| Travere Therapeutics, INC. | $214.95 | 2023-2025 | Filspari |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $192.94 | 2019-2022 | |
| Insulet Corporation | $188.25 | 2019-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $173.78 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $161.09 | 2019-2020 | |
| Antares Pharma, INC. | $149.46 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Otsuka America Pharmaceutical, INC. | $132.29 | 2019-2023 | Jynarque |
| Shield Therapeutics INC | $129.15 | 2023-2024 | Accrufer |
| Ardelyx, INC. | $123.48 | 2024-2025 | Ibsrela |
| Cequr Corporation | $122.92 | 2024-2025 | Cequr Simplicity |
| Novartis Pharmaceuticals Corporation | $117.07 | 2024-2025 | |
| Exact Sciences Corporation | $110.35 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $109.13 | 2019-2024 | |
| Amarin Pharma, INC. | $104.51 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $99.77 | 2022-2023 | Eliquis |
| Genzyme Corporation | $94.75 | 2022-2024 | |
| Mallinckrodt Hospital Products INC. | $86.00 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $84.36 | 2022-2025 | Strensiq, Ultomiris |
| Lifescan, INC. | $83.43 | 2019-2021 | |
| Astellas Pharma US INC | $78.52 | 2025 | Veozah |
| Mannkind Corporation | $76.56 | 2022 | |
| Ani Pharmaceuticals, INC. | $75.93 | 2022-2024 | Purified Cortrophin Gel |
| Valeritas, INC. | $57.43 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $53.74 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.73 | 2019-2023 | Gattex |
| Halozyme INC | $45.46 | 2023 | |
| Ascendis Pharma Endocrinology INC | $45.33 | 2025 | Yorvipath |
| Akebia Therapeutics INC | $45.03 | 2019 | |
| Calliditas Therapeutics US INC. | $41.15 | 2022-2024 | |
| Ultragenyx Pharmaceutical INC. | $40.67 | 2023 | |
| Radius Health, INC. | $39.43 | 2019 | |
| Scpharmaceuticals INC. | $34.65 | 2025 | |
| Horizon Therapeutics Plc | $34.15 | 2022 | |
| Medtronic Minimed, INC. | $26.53 | 2019 | |
| Alnylam Pharmaceuticals INC. | $25.60 | 2024 | Onpattro |
| Dexcom, INC. | $24.90 | 2024 | Dexcom G6 Transmitter |
| Beta Bionics, INC. | $22.89 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Mallinckrodt Enterprises LLC | $22.70 | 2019 | |
| Recor Medical INC | $22.54 | 2025 | Paradise Ultrasound Renal Denervation System |
| Amryt Pharma Holdings Ltd | $20.80 | 2021 | |
| Abbott Laboratories | $20.62 | 2021 | |
| Averitas Pharma INC. | $19.50 | 2023 | Qutenza |
| Ascensia Diabetes Care US INC. | $19.04 | 2021 | |
| Tandem Diabetes Care, INC. | $18.75 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Emami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.